PERKIN-ELMER BEEFING UP PROTEIN ANALYSIS OFFERINGS THROUGH $360 MIL. PERSEPTIVE BIOSYSTEMS ACQUISITION; DEAL TO CLOSE BY END OF YEAR
This article was originally published in The Gray Sheet
Executive Summary
Perkin-Elmer's $360 mil. acquisition of PerSeptive Biosystems would combine PerSeptive's strength in advanced protein analysis technology with PE's broad line of DNA sequencing technologies. The combination would create a fully integrated technology platform in the field of biomedical research and drug discovery, PE says.